2021

1. Head and neck cancer

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1393-1401

2. Immunotherapy in lung cancer

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1424-1428

3. Mesothelioma

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1402-1408

4. Molecular and cellular biomarkers. Implications for targeted therapy

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1418-1423

5. Non-small cell lung cancer

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1377-1387

6. Paciente gran superviviente con cáncer de cabeza y cuello metastásico y tratamiento con inmunoterapia

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1429.e1-1429.e3

7. Small cell lung cancer

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1369-1376

8. Therapeutic and palliative indications of radiotherapy in lung and thoracic tumors

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1409-1413

9. Therapeutic and palliative indications of surgery in lung and thoracic tumors

   Medicine (Spain), Vol. 13, Núm. 25, pp. 1414-1417

10. Thymic epithelial tumors. Thymoma

    Medicine (Spain), Vol. 13, Núm. 25, pp. 1388-1392

11. Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma

    The American Journal of dermatopathology, Vol. 43, Núm. 6, pp. 423-428